[ad_1]
For the drugs listed in the table, 10 pharmaceutical companies (Teva, Mylan Healthcare, GlaxoSmithkline, Sanofi, Pfizer, Novartis, Astra Zeneca, Novonordisk, Sandoz, Berlin Chemie. These pharmaceutical companies did not want to reduce the prices of 47 drugs), although the European countries offer similar therefore Lithuanian doctors lose the opportunity to prescribe these drugs to patients.
As announced this week, for this reason, doctors will not be able to prescribe up to 47 drugs to new patients starting in October, and will only be able to extend them to people who continue treatment. For new patients, doctors will be able to offer analog drugs that are just as effective.
SAM recalls that this week the Minister of Health Aurelijus Veryga officially addressed the representative offices of pharmaceutical companies in Lithuania and their headquarters, asking questions before 8 October. Reduce the prices of medicines so that they are similar to the prices of medicines offered in other European countries. Meanwhile, the State Health Insurance Fund (VLK) has been instructed to organize negotiations with these companies as a matter of urgency.
SAM notes that active substances are not excluded from the price list, which VLK updates four times a year. This means they can be re-prescribed to new patients at any time, as long as the manufacturers cut prices.
[ad_2]
